医学
妥珠单抗
银屑病性关节炎
内科学
类风湿性关节炎
不利影响
银屑病
人口
入射(几何)
皮肤病科
狼牙棒
依那西普
传统PCI
心肌梗塞
物理
环境卫生
光学
作者
Jeffrey R. Curtis,Xavier Mariette,Cécile Gaujoux-Viala,Andrew Blauvelt,Tore Kristian Kvien,William J. Sandborn,Kevin L. Winthrop,Marc De Longueville,I. Huybrechts,Vivian P. Bykerk
出处
期刊:RMD Open
[BMJ]
日期:2019-05-01
卷期号:5 (1): e000942-e000942
被引量:71
标识
DOI:10.1136/rmdopen-2019-000942
摘要
Objective: To review long-term certolizumab pegol (CZP) safety across all approved indications: rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO) and Crohn's disease (CD). Methods: Data were pooled across 49 UCB-sponsored CZP clinical trials (27 RA, one axSpA, one PsA, five PSO, 15 CD) to August 2017. Serious adverse events (SAEs) of interest (infections, malignancies, autoimmunity/hypersensitivity events, major adverse cardiovascular events (MACE), gastrointestinal (GI) perforations, psoriasis events, laboratory abnormalities) and deaths were medically reviewed by an external expert committee, using predefined case rules. Incidence rates (IRs)/100 patient-years (PY) are presented by indication; standardised mortality and malignancy rates were calculated using WHO/GLOBOCAN/SEER databases. Pregnancies with maternal CZP exposure are also reported. Results: Of 11 317 CZP-treated patients across indications (21 695 PY CZP exposure; maximum: 7.8 years), infections were the most common SAEs (overall IR: 3.62/100 PY; IRs ranged from 1.50/100 PY(PSO) to 5.97/100 PY(CD)). The IR for malignancies was 0.82/100 PY, including lymphoma (0.06/100 PY). MACE and GI perforation IRs in CZP-treated patients were 0.47/100 PY and 0.08/100 PY and were highest in RA and CD, respectively. Patients with PSO had the lowest SAE rates. The incidence of deaths and malignancies aligned with expected general population data. Conclusion: This extensive overview of the CZP safety profile in clinical trials, across all indications, provides large-scale confirmation of previous reports. No new safety signals or relevant non-disease-related laboratory abnormalities were identified. The study demonstrated some indication-specific differences in certain SAE rates that may be attributable to the underlying inflammatory disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI